Sagimet Biosciences SGMT
NASDAQ SGMT
$9.90 +0.16 (+1.69%)
As of: Oct 21, 2026 · 11:41 AM EDT

Sagimet Biosciences (SGMT) EBIT Margin (2023)

Updated

Sagimet Biosciences' EBIT Margin was -1537.00% in FY2023.

Analysis

Sagimet Biosciences (SGMT) EBIT Margin (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Sagimet Biosciences 524.24 Mn -50.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -372.60%
API Access

Sagimet Biosciences EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=SGMT&period=max&api_key=YOUR_API_KEY